OARS funding Cancer

The OCRP Teal Innovator Award supports a visionary individual from any field principally outside of, but not exclusive of, ovarian cancer to focus his/her creativity, innovation, and leadership on ovarian cancer research. The Teal Innovator Award will provide the Principal Investigator (PI) with the funding and freedom to pursue his/her most novel, visionary, high-risk ideas that could significantly impact the field of ovarian cancer research or patient care. The proposed Teal Innovator must be highly recognized in his/her field and present evidence of this recognition. Examples include, but are not limited to, recognition at the level of endowed chair; membership in the National Academy of Sciences, National Academy of Engineering, or Institute of Medicine; Chairmanship of the American Association for Cancer Research; or other national or international recognition.

The OCRP Ovarian Cancer Academy, which was initially created in FY09, is intended to be a unique, interactive virtual academy providing intensive mentoring, national networking, and a peer group for junior faculty. The overarching goal of the Ovarian Cancer Academy is to develop successful, highly productive ovarian cancer researchers in a collaborative research training environment. The current Ovarian Cancer Academy is a virtual career development and research training platform consisting of nine Early-Career Investigator/Designated Mentor pairs from different institutions and one Academy Dean. The Academy Dean serves as a resource for the Early-Career Investigators and Mentors, assesses the progress of the Early-Career Investigators, and facilitates communication and collaboration among all of the Early-Career Investigators and Mentors.

The Alfred P. Sloan Foundation makes grants on six broad subject matters, known within the Foundation as major program areas.  Basic Research STEM Higher Education Public Understanding of Science Economic Performance and the Quality of Life Select National Issues Civic Initiatives

The HERA Women's Cancer Foundation provides funds for a project focused on the cause, early detection, treatment, and/or understanding of ovarian cancer. This annual award provides $50,000 for a cross-disciplinary project that is collaborative in nature.  The application must identify two (or more) scientists with different yet complementary skills and explain how these skills will be synergistic in addressing the ovarian cancer problem.  Applications are now being accepted for the 2013 award.

This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to encourage research projects which focus on the interactions of carcinogenic pathogens with the human microbiome and the host for the detection of pathogen-induced cancer (DPIC). This FOA encourages research to assess molecular signatures associated with risk and early detection of pathogen-induced cancer and chronic inflammation associated with progression to invasive cancer.

his Funding Opportunity Announcement (FOA) invites research project (R01) applications that combine imaging and biomarkers. The overall objective of this FOA is to facilitate collaborative imaging and biomarker research to improve cancer screening, early cancer detection and diagnosis by integrating multi modality imaging strategies and multiplexed biomarker methodologies.

The Melanoma Research Foundation is accepting applications from emerging and established scientific investigators for research projects that explore new avenues in melanoma biology, prevention and treatments, with the goal of finding a cure. The foundation makes grants in four areas: Career Development Awards, Established Investigator Awards, Career Investigator CURE OM Awards, and Established Investigator CURE OM Awards. Career Development Awards provide funding of up to $50,000 a year for two years to junior investigators who are beginning a research career emphasizing melanoma-related projects and have not yet secured strong federal funding for their research. Established Investigator Awards provide funding of up to $100,000 a year for two years to established melanoma researchers or senior researchers working in closely related fields who wish to move into melanoma research. Career Development CURE OM Awards provide funding of up to $50,000 a year for two years to junior investigators in the ocular/uveal melanoma field. Established Investigator CURE OM Awards provides funding of up to $100,000 a year for two years to established ocular/uveal melanoma researchers, or senior researchers.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage new research into integrative cancer biology by fostering collaborations between investigators currently supported through the Integrative Cancer Biology Program (ICBP) and those currently unaffiliated with the ICBP. These collaborative projects should leverage the existing expertise and resources from within the ICBP research community and combine those with new approaches, technologies or methods to address compelling cancer questions. Therefore, the proposed research projects must involve partnerships between investigators currently supported by ICBP and investigators currently unaffiliated with the program. Applications that focus on projects which neither involve integrative cancer biology research, nor expand individual ICBP investigators' research by adding additional expertise, resources, or approaches, or without affiliation to existing ICBP personnel, are not appropriate to this FOA.

The MMRF is providing funding to researchers at the post doctorate/medical fellow or junior faculty levels and working under the supervision or guidance of a research sponsor in the multiple myeloma field.

This Funding Opportunity Announcement (FOA) solicits Exploratory/Developmental Grant (R21) applications to facilitate translational research in oral cancers by supporting studies aimed at understanding the cellular, molecular, and functional properties of oral Cancer Initiating Cells (CICs) and their niches.

This Funding Opportunity Announcement (FOA) solicits Research Project Grant (R01) applications to facilitate translational research in oral cancers by supporting studies aimed at understanding the cellular, molecular and functional properties of oral Cancer Initiating Cells (CICs) and their niches.

This funding opportunity announcement (FOA) issued by ORIP, National Institutes of Health, encourages research grant applications from institutions/organizations that propose to develop, characterize or improve animal models for human disease or to improve diagnosis and control of diseases that might interfere with animal use for biomedical research purposes.

Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. To this end, ACGT offers awards in Clinical Translation of Cell and Gene Therapy for Cancer, to qualified scientists at the assistant professor level and above. This award is specifically for those conducting Cell and Gene Therapy Research for Cancer and is entitled, 2013 Investigator's Award in Clinical Translation of Cell and Gene Therapy for Cancer.

The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).

Sociologists for Women in Society (SWS) works to improve women's lives through advancing and supporting feminist sociological research, activism and scholars. SWS is a nonprofit, scientific and educational organization with members in the U.S. and overseas. Its mission is to promote and disseminate research about women; educate colleagues, the general public, and government officials about the implications of research on women; offer help and mutual support to women and men who share the organization's concerns; take political action to improve women's lives; and maintain relationships with national and international organizations for women and the ending of discrimination against women.

The International Foundation for Ethical Research (IFER) is pleased to call for pre-proposal applications for its 2013 Graduate Student Fellowships for Alternatives to the Use of Animals in Science. The fellowships provide up to $12,500 annually in stipendiary support and up to $2,500 for supplies per year. The fellowships are renewable annually for up to three years. Continued funding is dependent on student progress and availability of funds.

The Leukemia & Lymphoma Society is accepting Letters of Intent from researchers for projects to identify and develop safer, more effective treatments for patients with blood cancers. Through the Quest for Cures initiative, LLS, in partnership with biopharmaceutical company Celgene, will award two-year grants of between $200,000 and $400,000 a year for research projects that have a measurable impact over the next five to ten years on the diagnosis or treatment of patients with hematologic malignancies. Additional funding may be available for projects that have demonstrated exceptional progress in the initial two years. Specifically, the initiative will award grants in the following priority areas: Tumor cell clonal heterogeneity: This grant will support researchers seeking novel approaches for measuring and monitoring clonal heterogeneity and assessing its contribution to the response or resistance to therapy. New molecular stratification mechanisms: Recipients of this grant will work to identify key subsets of patients with B-cell malignancies to help predict which patients will have poor outcomes from current standard therapies so they may be directed to alternative therapies. Bone marrow and lymph node microenvironments: Researchers will seek to enhance the understanding of the role that the bone marrow and lymph node microenvironments play in either responding to or resisting therapy.

As an initiative of the Office of Diversity and Inclusion, the Aspiring Physicians & Research Scientists Conference is a two-and-a-half day enhancement program that focuses on science innovation and world-class care. Cleveland Clinic physician and research scientist-led presentations and mentoring/coaching sessions provide students a unique opportunity to interface with our world renowned staff. An abstract poster competition provides students the opportunity to showcase their research. Our target audience includes underrepresented minority science, math and pre-med college students. It is designed to increase representation of American Indian, Black/African American, Hispanic/Latino, and Native Hawaiian/Pacific Islander physicians, research scientists, physician investigators and physician leaders. Applicants, who must be at least 18 years of age and currently enrolled in college majoring in math, science, or pre-med will be notified of acceptance via email by April 19, 2013. Research students interested in participating in the poster research scholarship competition must submit an abstract of their work by April 12, 2013. Applicants accepted to present their posters will be notified by email by April 19, 2013.